| Financial Year |
March 31 2023 |
| Monetary Funds |
533,194,613.69 |
| Held-for-trading Financial Assets |
151,540,000.00 |
| Notes Receivable |
21,945,755.73 |
| Accounts Receivable |
626,624,036.43 |
| Advances to Suppliers |
20,273,368.63 |
| Other Receivables |
10,417,155.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
625,900,838.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,658,943.74 |
| Total Current Assets |
2,231,440,573.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
394,149,078.58 |
| Investment Properties |
48,835,399.73 |
| Fixed Assetes |
1,614,649,594.03 |
| Under-construction Projects |
65,375,835.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
117,400,965.59 |
| R&D expenses |
-- |
| Goodwill |
569,743,492.60 |
| Long-Term Deferred and Prepaid Expenses |
13,462,627.76 |
| Deferred Income Tax Assets |
54,847,311.97 |
| Other Non-Current Assets |
27,800,250.31 |
| Sub-Total of Non-Current Assets |
3,050,847,231.25 |
| Total Assets |
5,282,287,804.55 |
| Short-Term Loans |
236,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
185,173,114.54 |
| Accounts Payable |
384,737,302.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,865,397.99 |
| Taxes Payable |
32,229,958.85 |
| Interest Payable |
728,248.54 |
| Dividend Payable |
60,291.20 |
| Other payables |
32,728,933.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
379,150,855.22 |
| Other Current Liabilities |
3,513,580.82 |
| Sub-Total of Current Liabilities |
1,339,529,302.19 |
| Long-term Loans |
296,214,348.52 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
18,379,408.62 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,622,080.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
533,362,307.34 |
| Total Liabilities |
1,872,891,609.53 |
| Paid-In Capital(Or Share Stock) |
588,409,646.00 |
| Capital Surplus |
571,566,713.33 |
| Surplus Reserve |
205,878,792.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,792,306,505.28 |
| Minority Stockholder's Interest |
244,375,767.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,165,020,427.59 |
| Owner's Equity（Stockholder's Equity） |
3,409,396,195.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,282,287,804.55 |
